Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy - an analysis of the DiaRegis registry

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Wasem, Jürgen ^a   Bramlage, Peter ^b   Gitt, Anselm K ^c   Binz, Christiane ^d   Krekler, Michael ^d   Deeg, Evelin ^c   Tschöpe, Diethelm ^e,f  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Institute für Pharmakologie und Präventive Medizin   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d BRISTOL MYERS SQUIBB   (United States)

^e Stiftung Der herzkranke Diabetiker in der Deutschen Diabetes Stiftung   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DYSGLYCEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; QUALITY OF LIFE; RETINOPATHY; TRANSIENT ISCHEMIC ATTACK;

ADMINISTRATION, ORAL; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGISTRIES; TREATMENT OUTCOME;

EID: 84875072840     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-47     Document Type: Article

References (31)

1. Lau CY, Qureshi AK, Scott SG. Association between glycaemic control and quality of life in diabetes mellitus. J Postgrad Med 2004, 50(3):189-193. discussion 194.
2. Nerenz DR, Repasky DP, Whitehouse FW, Kahkonen DM. Ongoing assessment of health status in patients with diabetes mellitus. Med Care 1992, 30(5 Suppl):MS112-MS124.
3. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999, 15(3):205-218. 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O, 10441043.
4. U.K. Prospective Diabetes Study Group Diabetes Study Group: Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999, 22(7):1125-1136. U.K. Prospective Diabetes Study Group.
5. Mayou R, Bryant B, Turner R. Quality of life in non-insulin-dependent diabetes and a comparison with insulin-dependent diabetes. J Psychosom Res 1990, 34(1):1-11. 10.1016/0022-3999(90)90002-L, 2313607.
6. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998, 280(17):1490-1496. 10.1001/jama.280.17.1490, 9809729.
7. Aalto AM, Uutela A, Aro AR. Health related quality of life among insulin-dependent diabetics: disease-related and psychosocial correlates. Patient Educ Couns 1997, 30(3):215-225. 10.1016/S0738-3991(96)00963-9, 9104378.
8. Menard J, Payette H, Dubuc N, Baillargeon JP, Maheux P, Ardilouze JL. Quality of life in type 2 diabetes patients under intensive multitherapy. Diabetes Metab 2007, 33(1):54-60. 10.1016/j.diabet.2006.09.001, 17258926.
9. Marra G, . Diab, Group TSPS The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy. Acta Biomed 2004, 75(3):164-170. Diab, Group TSPS.
10. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, Blais MA, Meigs JB. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006, 49(7):1489-1497. 10.1007/s00125-006-0249-9, 16752167.
11. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care 1999, 22(7):1125-1136.
12. Miksch A, Hermann K, Rolz A, Joos S, Szecsenyi J, Ose D, Rosemann T. Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany - a cross-sectional survey. Health Qual Life Outcomes 2009, 7:19. 10.1186/1477-7525-7-19, 2662813, 19250524.
13. Van Nispen RM, De Boer MR, Hoeijmakers JG, Ringens PJ, Van Rens GH. Co-morbidity and visual acuity are risk factors for health-related quality of life decline: five-month follow-up EQ-5D data of visually impaired older patients. Health Qual Life Outcomes 2009, 7:18. 10.1186/1477-7525-7-18, 2654874, 19243624.
14. Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, Mathieu C, Colin IM. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab 2009, 35(3):206-213. 10.1016/j.diabet.2008.11.004, 19297223.
15. Bramlage P, Binz C, Gitt AK, Krekler M, Plate T, Deeg E, Tschope D. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline. Cardiovasc Diabetol 2010, 9:53. 10.1186/1475-2840-9-53, 2949713, 20843379.
16. Gitt AK, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Tschope D. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry. Eur. J. Prev. Cardiol 2012, 19(4):765-772. 10.1177/1741826711411104, 21628353.
17. The EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208. The EuroQol Group.
18. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P. A single European currency for EQ-5D health states, Results from a six-country study. Eur J Health Econ 2003, 4(3):222-231. 10.1007/s10198-003-0182-5, 15609189.
19. Barton GR, Sach TH, Doherty M, Avery AJ, Jenkinson C, Muir KR. An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. Eur J Health Econ 2008, 9(3):237-249. 10.1007/s10198-007-0068-z, 17605057.
20. Grandy S, Fox KM. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health Qual Life Outcomes 2008, 6:18. 10.1186/1477-7525-6-18, 2266905, 18304340.
21. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095-1108. 10.1097/00005650-199711000-00002, 9366889.
22. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005, 6(2):124-130. 10.1007/s10198-004-0264-z, 19787848.
23. Johnson JA, Nowatzki TE, Coons SJ. Health-related quality of life of diabetic Pima Indians. Med Care 1996, 34(2):97-102. 10.1097/00005650-199602000-00001, 8632692.
24. Weinberger M, Kirkman MS, Samsa GP, Shortliffe EA, Landsman PB, Cowper PA, Simel DL, Feussner JR. A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med 1995, 10(2):59-66. 10.1007/BF02600227, 7730940.
25. Klein BE, Klein R, Moss SE. Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1998, 21(2):236-240. 10.2337/diacare.21.2.236, 9539988.
26. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997, 20(4):562-567. 10.2337/diacare.20.4.562, 9096981.
27. Jacobson AM, De Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994, 17(4):267-274. 10.2337/diacare.17.4.267, 8026281.
28. Tschope D, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Gitt AK. Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients-an analysis of the DiaRegis registry. Cardiovasc Diabetol 2011, 10:66. 10.1186/1475-2840-10-66, 3162488, 21756359.
29. Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschope D. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia. Cardiovasc Diabetol 2012, 11:122. 10.1186/1475-2840-11-122, 3508810, 23039216.
30. Alvarez-Guisasola F, Yin DD, Nocea G, Qiu Y, Mavros P. Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study. Health Qual Life Outcomes 2010, 8:86. 10.1186/1477-7525-8-86, 2936440, 20723229.
31. Daniele TM, Bruin VM, Oliveira DS, Pompeu CM, Forti AC. Associations among physical activity, comorbidities, depressive symptoms and health-related quality of life in type 2 diabetes. Arq Bras Endocrinol Metabol 2013, 57(1):44-50. 10.1590/S0004-27302013000100006, 23440098.